Revision Optics Secures $55,000,000 New Funding Round

  • Feed Type
  • Date
    7/30/2013
  • Company Name
    Revision Optics
  • Mailing Address
    25651 Atlantic Ocean Dr Lake Forest, CA 92630
  • Company Description
    The PRESBYLENS Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia. The PRESBYLENS CI, made from our proprietary microporous hydrogel material, is designed to be removable, adjustable and improve near vision with little or no compromise at distance.
  • Website
    http://www.revisionoptics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds provide our company with the necessary financial resources to carry us through the FDA PMA process for the Raindrop Near Vision Inlay and to expand our current commercial footprint outside the U.S.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    ProQuest Investments
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Domain Associates
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    RusnanoMedInvest

By posting a comment, you agree to our terms and conditions.